- Home
- ZIMV vs ARCT Comparison
ZIMV vs ARCT Comparison
Compare ZIMV & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- ARCT
- Stock Information
- Founded
- ZIMV 2021
- ARCT 2013
- Country
- ZIMV United States
- ARCT United States
- Employees
- ZIMV N/A
- ARCT N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- ZIMV Health Care
- ARCT Health Care
- Exchange
- ZIMV Nasdaq
- ARCT Nasdaq
- Market Cap
- ZIMV 355.5M
- ARCT 444.5M
- IPO Year
- ZIMV N/A
- ARCT N/A
- Fundamental
- Price
- ZIMV $12.52
- ARCT $13.21
- Analyst Decision
- ZIMV Buy
- ARCT Strong Buy
- Analyst Count
- ZIMV 2
- ARCT 7
- Target Price
- ZIMV $19.50
- ARCT $57.80
- AVG Volume (30 Days)
- ZIMV 132.3K
- ARCT 442.8K
- Earning Date
- ZIMV 02-26-2025
- ARCT 03-06-2025
- Dividend Yield
- ZIMV N/A
- ARCT N/A
- EPS Growth
- ZIMV N/A
- ARCT N/A
- EPS
- ZIMV N/A
- ARCT N/A
- Revenue
- ZIMV $449,749,000.00
- ARCT $152,310,000.00
- Revenue This Year
- ZIMV $3.38
- ARCT $17.02
- Revenue Next Year
- ZIMV $0.90
- ARCT $83.01
- P/E Ratio
- ZIMV N/A
- ARCT N/A
- Revenue Growth
- ZIMV N/A
- ARCT N/A
- 52 Week Low
- ZIMV $11.85
- ARCT $12.75
- 52 Week High
- ZIMV $22.40
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- ZIMV 38.60
- ARCT 33.27
- Support Level
- ZIMV $12.25
- ARCT $14.69
- Resistance Level
- ZIMV $13.70
- ARCT $16.20
- Average True Range (ATR)
- ZIMV 0.56
- ARCT 1.18
- MACD
- ZIMV -0.08
- ARCT -0.31
- Stochastic Oscillator
- ZIMV 33.67
- ARCT 9.00
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.